The Complexity of Consenting to Clinical Research in Phase I Pediatric Cancer Studies
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pediatrics, Perinatology and Child Health
Link
http://link.springer.com/content/pdf/10.1007/s40272-014-0113-1.pdf
Reference27 articles.
1. Lee DP, Skolnik JM, Adamson PC. Pediatric phase I trials in oncology: an analysis of study conduct efficiency. J Clin Oncol Off J Am Soc Clin Oncol. 2005;23(33):8431–41. doi: 10.1200/JCO.2005.02.1568 .
2. Cousino MK, Zyzanski SJ, Yamokoski AD, Hazen RA, Baker JN, Noll RB, et al. Communicating and understanding the purpose of pediatric phase I cancer trials. J Clin Oncol Off J Am Soc Clin Oncol. 2012;30(35):4367–72. doi: 10.1200/JCO.2012.42.3004 .
3. Morgenstern DA, Hargrave D, Marshall LV, Gatz SA, Barone G, Crowe T, et al. Toxicity and outcome of children and adolescents participating in phase I/II trials of novel anticancer drugs: the Royal Marsden experience. J Pediatr Hematol Oncol. 2014;36(3):218–23. doi: 10.1097/MPH.0000000000000003 .
4. Ackerman TF. The ethics of phase I pediatric oncology trials. Irb. 1995;17(1):1–5.
5. Joffe S, Miller FG. Rethinking risk–benefit assessment for phase I cancer trials. J Clin Oncol Off J Am Soc Clin Oncol. 2006;24(19):2987–90. doi: 10.1200/JCO.2005.04.9296 .
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. What information and the extent of information to be provided in an informed assent/consent form of pediatric drug trials;BMC Medical Ethics;2022-11-16
2. Impact of pharmacogenetics on variability in exposure to oral vinorelbine among pediatric patients: a model‐based population pharmacokinetic analysis;Cancer Chemotherapy and Pharmacology;2022-06-25
3. End-of-Life Childhood Cancer Research: A Systematic Review;Pediatrics;2021-03-01
4. Efficacy and Safety of Metformin for Obesity: A Systematic Review;Pediatrics;2021-03-01
5. Revisiting Risk and Benefit in Early Oncology Trials in the Era of Precision Medicine: A Systematic Review and Meta-Analysis of Phase I Trials of Targeted Single-Agent Anticancer Therapies;JCO Precision Oncology;2021-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3